AI
ABMD

Axiom Investors’s Abiomed Inc ABMD Stock Holding History

Axiom Investors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-39,344
Closed -$10.2M – 128
2019
Q2 		$10.2M Sell
39,344
-9,884
-20% -$2.62M 0.28% 54
2019
Q1 		$14.1M Buy
49,228
+5,108
+12% +$1.7M 0.43% 46
2018
Q4 		$14.3M Buy
44,120
+9,716
+28% +$3.38M 0.5% 50
2018
Q3 		$15.5M Buy
+34,404
New +$13.6M 0.44% 51

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Axiom Investors's ABMD Position: Q3 2019 in Review

Axiom Investors sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 39,344 shares — an estimated $10.2M sold.

Axiom Investors first reported a position in ABMD in Q3 2018 and held it in 4 quarters. The position peaked at $15.5M in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Axiom Investors reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Axiom Investors sold 39,344 Abiomed Inc shares in Q3 2019, an estimated $10.2M.
  • Axiom Investors first reported a position in Abiomed Inc in Q3 2018 and held it in 4 quarters.
  • Axiom Investors's Abiomed Inc position peaked at $15.5M in Q3 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Axiom Investors's 13F filing for Q3 2019, filed 13 Nov 2019.